» Articles » PMID: 35070470

Epidemiologic Characteristics, Clinical Management, and Public Health Implications of Coronavirus Disease 2019 (COVID-19) in Pregnancy: A Systematic Review and Meta-analysis

Abstract

Background: The novel Coronavirus Disease 2019 (COVID-19) outbreak, caused by the pathogenic severe acute respiratory syndrome-2 (SARS-CoV-2) virus, is exponentially spreading across the globe.

Methods: The current systematic review was performed utilising the following electronic databases PubMed, MEDLINE and EMBASE. We searched for the keywords "COVID-19 AND "pregnancy" between January 1, 2020 until December 31, 2020.

Results: Out of 4005 records which were identified, 36 original studies were included in this systematic review. Pooled prevalence of vertical transmission was 10%, 95% CI: 4-17%. Pooled prevalence of neonatal mortality was 7%, 95% CI: 0-21%.

Conclusion: The contemporary evidence suggests that the incubation period of COVID-19 is 2-14 days, and this infection could be transmitted even from the infected asymptomatic individuals. It is found that the clinical presentation of pregnant women with COVID-19 infection is comparable with the infected non-pregnant females, and the frequent symptoms were fever, cough, myalgia, sore throat and malaise. Some cases have severe maternal morbidity and perinatal deaths secondary to COVID-19 infection. Under these circumstances, pregnant women should focus on maintaining personal hygiene, proper nutrition and extreme social distancing to reduce the risk of COVID-19. Therefore, systematic data reporting for evidence based clinical assessment, management and pregnancy outcomes is essential for preventing of COVID-19 infection among pregnant women.

Citing Articles

Impact of the Coronavirus Disease (COVID-19) Pandemic on Neonatal Nutrition: Focus on Low- and Middle-Income Countries.

Nyirongo M, Agrawal N, Rojas A, Barbour K Curr Trop Med Rep. 2022; 9(4):218-224.

PMID: 36415223 PMC: 9672601. DOI: 10.1007/s40475-022-00272-7.


Challenges and difficulties faced in low- and middle-income countries during COVID-19.

Hossain M, Abdulla F, Rahman A Health Policy Open. 2022; 3:100082.

PMID: 36405972 PMC: 9642028. DOI: 10.1016/j.hpopen.2022.100082.


Hypophosphatemia in Coronavirus Disease 2019 (COVID-19), Complications, and Considerations: A Systematic Review.

Fakhrolmobasheri M, Vakhshoori M, Heidarpour M, Najimi A, Mozafari A, Rezvanian H Biomed Res Int. 2022; 2022:1468786.

PMID: 36312855 PMC: 9616661. DOI: 10.1155/2022/1468786.


Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) including Variant Analysis by Mass Spectrometry in Placental Tissue.

Wierz M, Sauerbrei B, Wandernoth P, Kriegsmann M, Casadonte R, Kriegsmann K Viruses. 2022; 14(3).

PMID: 35337011 PMC: 8953811. DOI: 10.3390/v14030604.

References
1.
Khan S, Jun L, Nawsherwan , Siddique R, Li Y, Han G . Association of COVID-19 with pregnancy outcomes in health-care workers and general women. Clin Microbiol Infect. 2020; 26(6):788-790. PMC: 7141623. DOI: 10.1016/j.cmi.2020.03.034. View

2.
Cao D, Yin H, Chen J, Tang F, Peng M, Li R . Clinical analysis of ten pregnant women with COVID-19 in Wuhan, China: A retrospective study. Int J Infect Dis. 2020; 95:294-300. PMC: 7179499. DOI: 10.1016/j.ijid.2020.04.047. View

3.
Yang H, Sun G, Tang F, Peng M, Gao Y, Peng J . Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019. J Infect. 2020; 81(1):e40-e44. PMC: 7152867. DOI: 10.1016/j.jinf.2020.04.003. View

4.
Liu D, Li L, Wu X, Zheng D, Wang J, Yang L . Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis. AJR Am J Roentgenol. 2020; 215(1):127-132. DOI: 10.2214/AJR.20.23072. View

5.
Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2):631-7. PMC: 7167720. DOI: 10.1002/path.1570. View